PATENT CLAIM ANALYSIS

Application Number: 16313360
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["424", "001110"]

Abstract:
The present invention relates to an aryl ethene derivative, for inhibiting an estrogen-related receptor gamma (ERRγ) activity, a prodrug of same, a solvate of same, a stereoisomer of same or pharmaceutically acceptable salts of same, and a pharmaceutical composition containing same as an active ingredient.

Claim (Index 9):
The pharmaceutical composition of  claim 7 , wherein R 2  is hydroxy; R 1  is \u2014O\u2014(CH 2 ) m \u2014R 11 ; m is an integer of 1 or 2; and R 11  is heterocycloalkyl selected from the following structures: wherein R 31  and R 32  are independently of each other halogen, (C1-C100)alkyl, (C1-C10)alkoxycarbonyl, or hydroxy(C1-C10)alkyl; and L is O or S.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.43243
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15102968', '12704343', '11829531', '13098247', '14473147']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7017039233459318
- 35 USC 102 Novelty (BERT): 0.5258178648664033
- Combined Prediction Score: 0.6841153174979789
- Mean Citation Score: 290.742902
- Max Citation Score: 305.64383
- Similarity Product: 209.52850876480105

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test